IPO Trending
SPMLSME / BSEListed

Speciality Medicines Limited

Speciality Medicines Limited was incorporated in 2021 and focuses on marketing and distributing speciality pharmaceutical medicines, including expensive oral and injectable drugs used to treat serious and long-term health conditions in both Indian and international markets. The company offers many types of finished pharmaceutical products in different forms such as tablets, capsules, creams, syrups, eye drops, gels, injections, inhalers, nasal sprays, ointments, sachets, and suspensions. It operates through two main models: contract manufacturing of finished medicines for international markets and marketing and distribution of speciality medicines sourced from other manufacturers. The company has expanded globally with products registered or under registration in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia, and its distribution network covers more than 20 states in India and over 35 countries worldwide. As of March 31, 2025, one product was registered overseas and 60 products were under registration in five countries, contributing to revenue, and as of August 31, 2025, the company had 18 permanent employees working in different departments.

₹117 - ₹1242.33x sub
Listed Price124.00
Listing Gain+0.00%
Peer Comparison-Financial performance and valuation from the IPO detail feed
Financial Performance

Speciality Medicines Limited

NAV/Share (₹)47.26
RONW(%)28.42
EPS (Basic) (₹)14.10

Remus Pharmaceuticals Limited

NAV/Share (₹)434.25
RONW(%)15.02
EPS (Basic) (₹)65.21

Trident Lifeline Limited

NAV/Share (₹)56.05
RONW(%)18.23
EPS (Basic) (₹)10.22

Mono Pharmacare Limited

NAV/Share (₹)17.66
RONW(%)9.90
EPS (Basic) (₹)1.75
Valuation

Speciality Medicines Limited

P/E(X)9.27
CMP* (₹)0
Face value (₹)10.00

Remus Pharmaceuticals Limited

P/E(X)10.41
CMP* (₹)0
Face value (₹)10.00

Trident Lifeline Limited

P/E(X)27.00
CMP* (₹)0
Face value (₹)10.00

Mono Pharmacare Limited

P/E(X)7.49
CMP* (₹)0
Face value (₹)10.00